Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Heikki Joensuu. (2000) Novel cancer therapies: more efficacy, less toxicity and improved organ preservation. Annals of Medicine 32:1, pages 31-33.
Read now
Read now
Articles from other publishers (25)
Meixuan Li, Xiuxia Li, Liang Yao, Xue Han, Wenlong Yan, Yujun Liu, Yiwen Fu, Yakun Wang, Min Huang, Qiuning Zhang, Xiaohu Wang & Kehu Yang. (2021) Clinical Efficacy and Safety of Proton and Carbon Ion Radiotherapy for Prostate Cancer: A Systematic Review and Meta-Analysis. Frontiers in Oncology 11.
Crossref
Crossref
Yosuke Takakusagi, Hiroyuki Katoh, Kio Kano, Wataru Anno, Keisuke Tsuchida, Nobutaka Mizoguchi, Itsuko Serizawa, Daisaku Yoshida & Tadashi Kamada. (2020) Preliminary result of carbon-ion radiotherapy using the spot scanning method for prostate cancer. Radiation Oncology 15:1.
Crossref
Crossref
Ting Yu, Qiongwen Zhang, Tianying Zheng, Huashan Shi, Yang Liu, Shijian Feng, Meiqin Hao, Lei Ye, Xueqian Wu & Cheng Yang. (2016) The Effectiveness of Intensity Modulated Radiation Therapy versus Three-Dimensional Radiation Therapy in Prostate Cancer: A Meta-Analysis of the Literatures. PLOS ONE 11:5, pages e0154499.
Crossref
Crossref
Sara FerreiraIrene DormehlMaria Filomena Botelho. (2012) Radiopharmaceuticals for Bone Metastasis Therapy and Beyond: A Voyage from the Past to the Present and a Look to the Future. Cancer Biotherapy and Radiopharmaceuticals 27:9, pages 535-551.
Crossref
Crossref
Karel Odrazka, Martin Dolezel, Jaroslav Vanasek, Miloslava Vaculikova, Milan Zouhar, Jana Sefrova, Petr Paluska, Milan Vosmik, Tereza Kohlova, Iveta Kolarova, Pavel Navratil, Milos Brodak, Petr Prosvic & Petr Hoffmann. (2010) Late toxicity after conformal and intensity-modulated radiation therapy for prostate cancer: Impact of previous surgery for benign prostatic hyperplasia. International Journal of Urology 17:9, pages 784-790.
Crossref
Crossref
Louis Keiler, Donald Dobbins, Ravi Kulasekere & Douglas Einstein. (2007) Tomotherapy for prostate adenocarcinoma: A report on acute toxicity. Radiotherapy and Oncology 84:2, pages 171-176.
Crossref
Crossref
Andy W. Su & Ashesh B. Jani. (2007) Chronic Genitourinary and Gastrointestinal Toxicity of Prostate Cancer Patients Undergoing Pelvic Radiotherapy With Intensity-Modulated Versus 4-Field Technique. American Journal of Clinical Oncology 30:3, pages 215-219.
Crossref
Crossref
A B Jani, A Su, D Correa & J Gratzle. (2006) Comparison of late gastrointestinal and genitourinary toxicity of prostate cancer patients undergoing intensity-modulated versus conventional radiotherapy using localized fields. Prostate Cancer and Prostatic Diseases 10:1, pages 82-86.
Crossref
Crossref
Ashesh B. Jani, John Gratzle & David Correa. (2016) Influence of Intensity-Modulated Radiotherapy on Acute Genitourinary and Gastrointestinal Toxicity in the Treatment of Localized Prostate Cancer. Technology in Cancer Research & Treatment 6:1, pages 11-15.
Crossref
Crossref
X. Artignan, M. Rastkhah, J. Balosso, P. Fourneret, O. Gilliot & M. Bolla. (2006) Quantification des mouvements prostatiques lors de l'irradiation prostatique. Cancer/Radiothérapie 10:6-7, pages 381-387.
Crossref
Crossref
Ashesh B. Jani, Andy Su & Michael T. Milano. (2006) Intensity-modulated versus conventional pelvic radiotherapy for prostate cancer: Analysis of acute toxicity. Urology 67:1, pages 147-151.
Crossref
Crossref
Cheol Kwak, Sung Kyu Hong, Seung Kyoo Seong, Jei Man Ryu, Moon Soo Park & Sang Eun Lee. (2005) Effective local control of prostate cancer by intratumoral injection of 166Ho-chitosan complex (DW-166HC) in rats. European Journal of Nuclear Medicine and Molecular Imaging 32:12, pages 1400-1405.
Crossref
Crossref
P. Mongiat-Artus & P. Teillac. (2005) Role of Luteinising Hormone Releasing Hormone (LHRH) Agonists and Hormonal Treatment in the Management of Prostate Cancer. European Urology Supplements 4:5, pages 4-13.
Crossref
Crossref
Michel J. Ghilezan, David A. Jaffray, Jeffrey H. Siewerdsen, Marcel Van Herk, Anil Shetty, Michael B. Sharpe, Syed Zafar Jafri, Frank A. Vicini, Richard C. Matter, Donald S. Brabbins & Alvaro A. Martinez. (2005) Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). International Journal of Radiation Oncology*Biology*Physics 62:2, pages 406-417.
Crossref
Crossref
Ashesh B. Jani, John Gratzle, Emil Muresan, Karl Farrey & Mary K. Martel. (2005) Analysis of acute toxicity with use of transabdominal ultrasonography for prostate positioning during intensity-modulated radiotherapy. Urology 65:3, pages 504-508.
Crossref
Crossref
Ashesh B. Jani, John Gratzle, Emil Muresan & Mary K. Martel. (2016) Impact on Late Toxicity of using Transabdominal Ultrasound for Prostate Cancer Patients Treated with Intensity Modulated Radiotherapy. Technology in Cancer Research & Treatment 4:1, pages 115-120.
Crossref
Crossref
Ashesh B. Jani, Christopher M. Hand, Anthony E. Lujan, John C. Roeske, Gregory P. Zagaja, Srinivasan Vijayakumar & Charles A. Pelizzari. (2004) Biological effective dose for comparison and combination of external beam and low-dose rate interstitial brachytherapy prostate cancer treatment plans. Medical Dosimetry 29:1, pages 42-48.
Crossref
Crossref
Ashesh B. Jani, John C. Roeske & Carla Rash. (2003) Intensity-Modulated Radiation Therapy for Prostate Cancer. Clinical Prostate Cancer 2:2, pages 98-105.
Crossref
Crossref
Ashesh B. Jani, Anirban Basu, Ibrahim Abdalla, Phillip P. Connell, Lani Krauz & Srinivasan Vijayakumar. (2003) Impact of Hormone Therapy When Combined With External Beam Radiotherapy for Early-Stage, Intermediate-, or High-Risk Prostate Cancer. American Journal of Clinical Oncology 26:4, pages 382-385.
Crossref
Crossref
Patrick A Kupelian, Chandana A Reddy, Thomas P Carlson, Kimberley A Altsman & Twyla R Willoughby. (2002) Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer. International Journal of Radiation Oncology*Biology*Physics 53:4, pages 904-912.
Crossref
Crossref
Frank A Vicini, Anthony Abner, Kathy L Baglan, Larry L Kestin & Alvaro A Martinez. (2001) Defining a dose–response relationship with radiotherapy for prostate cancer: is more really better?. International Journal of Radiation Oncology*Biology*Physics 51:5, pages 1200-1208.
Crossref
Crossref
Georgi Pirtskhalaishvili, Ronald L. Hrebinko & Joel B. Nelson. (2008) The Treatment of Prostate Cancer. . Cancer Practice 9:6, pages 295-306.
Crossref
Crossref
Georgi Pirtskhalaishvili, Ronald L. Hrebinko & Joel B. Nelson. (2001) The Treatment of Prostate Cancer. . An Overview of Current Options. Cancer Practice 9:6, pages 295-306.
Crossref
Crossref
Patrick A Kupelian, Chandana A Reddy, Eric A Klein & Twyla R Willoughby. (2001) Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life. International Journal of Radiation Oncology*Biology*Physics 51:4, pages 988-993.
Crossref
Crossref
Don Carlson. (2001) Intensity modulation using multileaf collimators: current status. Medical Dosimetry 26:2, pages 151-156.
Crossref
Crossref